Pathology & Microbiology
Learn disease mechanisms and infectious agents
Bacterial Cell Structure and Physiology
Master bacterial cell structure and physiology with free flashcards and spaced repetition practice. This lesson covers prokaryotic cell components, bacterial cell walls, specialized structures, and metabolic characteristicsβessential concepts for USMLE Step 1 Pathology and Microbiology.
Welcome to Bacterial Cell Structure! π¦
Understanding bacterial anatomy and physiology is fundamental to medical microbiology. These concepts form the foundation for understanding antibiotic mechanisms, pathogenicity, and laboratory identification methods. Whether you're facing USMLE questions about cell wall synthesis inhibitors or identifying bacteria by their structural features, this comprehensive guide will prepare you.
Core Concepts
Prokaryotic vs. Eukaryotic Cells π¬
Prokaryotic cells (bacteria) differ fundamentally from eukaryotic cells (human cells). These differences are clinically significant because they represent targets for selective antimicrobial therapy.
| Feature | Prokaryotes (Bacteria) | Eukaryotes (Human Cells) |
|---|---|---|
| Nucleus | No membrane-bound nucleus; nucleoid region | Membrane-bound nucleus |
| DNA | Circular chromosome + plasmids | Linear chromosomes |
| Ribosomes | 70S (30S + 50S subunits) | 80S (40S + 60S subunits) |
| Cell Wall | Peptidoglycan (most bacteria) | None |
| Organelles | None (no mitochondria, ER, Golgi) | Multiple membrane-bound organelles |
| Size | 0.5-5 ΞΌm | 10-100 ΞΌm |
π‘ Clinical Pearl: The 70S ribosome is targeted by many antibiotics (tetracyclines, aminoglycosides, macrolides) without affecting human 80S ribosomes!
Bacterial Cell Wall Structure π§±
The cell wall is the most clinically important bacterial structure, serving as the primary target for Ξ²-lactam antibiotics and the basis for Gram staining.
Peptidoglycan (Murein)
Peptidoglycan is a mesh-like polymer unique to bacteria, consisting of:
- Glycan chains: Alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)
- Peptide cross-links: Short peptides (typically tetrapeptides) connecting glycan strands
PEPTIDOGLYCAN STRUCTURE
NAGβNAMβNAGβNAMβNAGβNAM
β β β
peptide peptide peptide
β β β
cross-link β cross-link
β β β
NAGβNAMβNAGβNAMβNAGβNAM
β β β
peptide peptide peptide
NAG = N-acetylglucosamine
NAM = N-acetylmuramic acid
Gram-Positive vs. Gram-Negative Cell Walls
The Gram stain differentiates bacteria based on cell wall structureβa critical first step in identification and treatment selection.
GRAM STAINING COMPARISON
GRAM-POSITIVE GRAM-NEGATIVE
βββββββββββββββ βββββββββββββββ
β Purple β β Pink β
βββββββββββββββ βββββββββββββββ
Peptidoglycan (thick) Outer membrane
ββββββββββββββββ βββββββββββββββ
ββββββββββββββββ Thin peptidoglycan
ββββββββββββββββ βββββββββββββββ
ββββββββββββββββ Periplasmic space
ββββββββββββββββ βββββββββββββββ
Cytoplasmic membrane Cytoplasmic membrane
ββββββββββββββββ βββββββββββββββ
Cytoplasm Cytoplasm
| Component | Gram-Positive | Gram-Negative |
|---|---|---|
| Peptidoglycan Layer | Thick (20-80 nm, multiple layers) | Thin (2-7 nm, single layer) |
| Outer Membrane | Absent | Present |
| Teichoic Acids | Present (wall and lipoteichoic acids) | Absent |
| Lipopolysaccharide (LPS) | Absent | Present (endotoxin) |
| Periplasmic Space | Absent or minimal | Present (contains enzymes, including Ξ²-lactamases) |
| Gram Stain Result | Purple/blue (retains crystal violet) | Pink/red (retains safranin counterstain) |
π§ Mnemonic for Gram-Negative Features: "POLLEN"
- Periplasmic space
- Outer membrane
- Lipopolysaccharide (LPS/endotoxin)
- Less peptidoglycan
- Endotoxin activity
- Negative stain (pink)
Lipopolysaccharide (LPS) - The Endotoxin β οΈ
LPS is found only in Gram-negative bacteria and is a potent immunostimulant.
LPS STRUCTURE
O-antigen (O-polysaccharide)
βββββββββββββββ Variable, antigenic
βββββββββββββββββββ
Core polysaccharide Conserved
βββββββββββββββββββ
Lipid A Toxic component
βββββββββββββββββββ
Outer membrane
Clinical Significance of LPS/Endotoxin:
- Lipid A: The toxic moiety that triggers immune response
- Activates macrophages β release of IL-1, IL-6, TNF-Ξ±
- Causes fever, hypotension, DIC (disseminated intravascular coagulation)
- Responsible for septic shock in Gram-negative bacteremia
- Heat-stable (unlike exotoxins, which are typically heat-labile proteins)
π‘ USMLE High-Yield: Endotoxin = LPS = Lipid A component. It's detected by TLR4 (Toll-like receptor 4) on immune cells.
Bacterial Cell Membrane π§¬
The cytoplasmic membrane (plasma membrane) is a phospholipid bilayer without sterols (except Mycoplasma).
Functions:
- Selective permeability: Controls entry/exit of substances
- Energy generation: Contains electron transport chain (bacteria lack mitochondria)
- Biosynthesis: Site of lipid and cell wall synthesis
- Transport systems: Active and passive transport proteins
π¬ Antibiotic Target: Polymyxins (polymyxin B, colistin) disrupt bacterial cell membranes by binding to LPS and phospholipids.
Specialized Bacterial Structures π―
Capsule
The capsule is a polysaccharide (or rarely polypeptide) coating outside the cell wall.
Functions:
- Antiphagocytic: Primary virulence factor preventing phagocytosis
- Adherence: Helps bacteria attach to surfaces
- Protection: Against desiccation and antibiotics
Clinical Importance:
- Quellung reaction: Capsule swelling when exposed to specific antisera (used for Streptococcus pneumoniae identification)
- Vaccines: Capsular polysaccharides used in pneumococcal, meningococcal, and H. influenzae type b vaccines
- Polysaccharide capsule bacteria typically cause severe infections in asplenic patients
π§ Mnemonic for Encapsulated Bacteria: "Please SHINES my SKiS"
- Pseudomonas aeruginosa
- Streptococcus pneumoniae
- Haemophilus influenzae type b
- Neisseria meningitidis
- Escherichia coli (some strains, especially K1)
- Salmonella typhi
- Klebsiella pneumoniae
- Streptococcus agalactiae (Group B Strep, type III)
Flagella
Flagella are protein appendages providing motility.
| Arrangement | Description | Example |
|---|---|---|
| Monotrichous | Single polar flagellum | Vibrio cholerae |
| Lophotrichous | Tuft of flagella at one pole | Helicobacter pylori |
| Amphitrichous | Flagella at both poles | Some spirilla |
| Peritrichous | Flagella distributed over entire surface | E. coli, Salmonella, Proteus |
Structure: Made of flagellin protein arranged in a helical structure
Clinical Note: The H antigen (from German "Hauch" = breath/film) refers to flagellar antigens used in bacterial serotyping (e.g., Salmonella typing).
FLAGELLAR ARRANGEMENTS
Monotrichous Lophotrichous
β βββ
β βββ
β±ββ² β±ββ²
β β’ β β β’ β
β²ββ± β²ββ±
Amphitrichous Peritrichous
β β β β β
β β ββ β ββ
β±ββ² β±ββ² β±ββ²
β β’ β β β’ β
β²ββ± β²ββ±
β β ββ β ββ
β β β β β
Pili (Fimbriae)
Pili are hair-like protein appendages distinct from flagella.
Types:
- Common pili (fimbriae): Numerous short structures for attachment
- Example: E. coli P-pili bind to kidney epithelium (pyelonephritis)
- Sex pili (F pili): Longer, fewer in number; mediate bacterial conjugation (DNA transfer)
π‘ USMLE Tip: Pili = attachment and conjugation. Flagella = motility. Don't confuse them!
Spores (Endospores)
Endospores are dormant, highly resistant structures formed by certain Gram-positive bacteria.
Spore-forming bacteria (clinically important):
- Bacillus species: B. anthracis, B. cereus
- Clostridium species: C. tetani, C. botulinum, C. perfringens, C. difficile
- Coxiella burnetii: Only obligate intracellular bacterium that forms spore-like structures
Spore structure:
ENDOSPORE STRUCTURE
βββββββββββββββββββ
β Exosporium β Outer protein coat
βββββββββββββββββββ€
β Spore coat β Keratin-like proteins
βββββββββββββββββββ€
β Cortex β Peptidoglycan
βββββββββββββββββββ€
β Core β DNA, ribosomes,
β (with calcium β dipicolinic acid
β dipicolinate) β
βββββββββββββββββββ
Spore resistance:
- Heat: Can survive boiling (100Β°C); requires autoclaving (121Β°C, 15 min) for sterilization
- Desiccation: Survive for years in dry conditions
- Radiation: More resistant than vegetative cells
- Chemicals: Resistant to many disinfectants
- Enzymes: Resistant to lysozyme
β οΈ Clinical Implication: Spores require sterilization (not just disinfection). Autoclaving is the gold standard for eliminating spores from medical equipment.
π§ Mnemonic for Spore-Formers: "Bacillus and Clostridium make Spores" (just remember B and C!)
Bacterial Genetic Material π§¬
Nucleoid (Bacterial Chromosome)
- Single circular chromosome: Double-stranded DNA, not enclosed in a membrane
- Supercoiled: Organized by DNA-binding proteins (not histones like in eukaryotes)
- Haploid: Single copy of genome
Plasmids
Plasmids are extrachromosomal circular DNA molecules.
Clinical Significance:
- Antibiotic resistance genes: Often carried on plasmids (e.g., Ξ²-lactamase genes)
- Virulence factors: Toxins, adhesins (e.g., enterotoxigenic E. coli heat-labile toxin)
- Transferable: Via conjugation, transformation, or transduction
- R-plasmids (resistance plasmids): Contain multiple antibiotic resistance genes
π‘ USMLE High-Yield: Plasmids can be transferred between bacteria, spreading antibiotic resistance rapidly!
Bacterial Metabolism & Growth π
Oxygen Requirements
| Type | Oβ Requirement | Catalase | Superoxide Dismutase | Examples |
|---|---|---|---|---|
| Obligate Aerobes | Require Oβ | + | + | Pseudomonas, Mycobacterium tuberculosis |
| Obligate Anaerobes | Killed by Oβ | β | β | Clostridium, Bacteroides, Actinomyces |
| Facultative Anaerobes | Use Oβ if available, but can survive without | + | + | E. coli, Staphylococcus, most streptococci |
| Microaerophiles | Require low Oβ (5-10%) | +/β | + | Campylobacter, Helicobacter |
| Aerotolerant Anaerobes | Don't use Oβ, but tolerate it | β | + | Streptococcus pyogenes |
π§ Mnemonic for Obligate Aerobes: "Nagging Pests Must Breathe"
- Nocardia
- Pseudomonas aeruginosa
- Mycobacterium tuberculosis
- Bacillus (most species)
π§ Mnemonic for Obligate Anaerobes: "Anaerobes Can't Breathe Air"
- Actinomyces
- Clostridium
- Bacteroides
- Actinomyces (yes, repeated for emphasis!)
Bacterial Culture Media
| Media Type | Purpose | Examples |
|---|---|---|
| Enriched Media | Contain additional nutrients for fastidious organisms | Blood agar, chocolate agar |
| Selective Media | Inhibit unwanted organisms, allow desired ones | MacConkey agar (Gram-negatives), Thayer-Martin agar (Neisseria) |
| Differential Media | Distinguish organisms based on biochemical properties | MacConkey agar (lactose fermentation), EMB agar |
| Indicator Media | Contain pH indicators showing metabolic activity | MacConkey (pH indicator for lactose fermentation) |
π‘ Clinical Pearl: MacConkey agar is both selective (bile salts inhibit Gram-positives) and differential (lactose fermenters turn pink, non-fermenters remain colorless).
Examples with Clinical Correlations
Example 1: Ξ²-Lactam Antibiotics and Peptidoglycan Synthesis π
Clinical Scenario: A patient with pneumonia is started on amoxicillin, a Ξ²-lactam antibiotic.
Mechanism: Ξ²-lactam antibiotics (penicillins, cephalosporins, carbapenems) inhibit bacterial cell wall synthesis by:
- Structural mimicry: Ξ²-lactam ring resembles D-Ala-D-Ala terminus of peptide side chains
- Target: Bind to penicillin-binding proteins (PBPs), which are transpeptidases
- Effect: Prevent cross-linking of peptidoglycan chains
- Result: Weak cell wall β osmotic lysis (bactericidal effect)
NORMAL PEPTIDOGLYCAN SYNTHESIS
NAGβNAMβNAGβNAM
β β
peptide peptide
β β
PBP cross-links β Strong wall
β β
NAGβNAMβNAGβNAM
WITH Ξ²-LACTAM ANTIBIOTIC
NAGβNAMβNAGβNAM
β β
peptide peptide
β β
β PBP blocked β Weak wall
(no cross-links) β Cell lysis
NAGβNAMβNAGβNAM
Why bacteria die:
- Osmotic pressure inside bacterial cell is high (5-20 atm)
- Without intact peptidoglycan, cell membrane ruptures
- Only effective against actively growing bacteria (need cell wall synthesis)
Resistance mechanisms:
- Ξ²-lactamases: Enzymes that cleave Ξ²-lactam ring (e.g., ESBL, carbapenemases)
- Altered PBPs: Modified binding site (e.g., MRSA has PBP2a)
- Decreased permeability: Reduced drug entry (Gram-negatives)
- Efflux pumps: Actively pump drug out
Example 2: Gram Stain Mechanism and Clinical Use π¬
Clinical Scenario: A patient presents with meningitis. CSF shows Gram-positive cocci in pairs.
Gram Stain Procedure:
| Step | Reagent | Gram-Positive Result | Gram-Negative Result |
|---|---|---|---|
| 1. Primary stain | Crystal violet | Purple | Purple |
| 2. Mordant | Iodine | Purple (CV-I complex trapped) | Purple (CV-I complex formed) |
| 3. Decolorization | Alcohol or acetone | Remains purple (thick peptidoglycan retains dye) | Becomes colorless (thin peptidoglycan loses dye) |
| 4. Counterstain | Safranin (red/pink) | Remains purple (already stained) | Turns pink/red |
Why the difference?
- Gram-positive: Thick peptidoglycan (20-80 nm) traps crystal violet-iodine complex
- Gram-negative: Thin peptidoglycan (2-7 nm) cannot retain complex; alcohol dissolves outer membrane lipids, allowing dye to escape
Clinical interpretation (from scenario):
- Gram-positive cocci in pairs = likely Streptococcus pneumoniae
- Immediate treatment: Ceftriaxone + vancomycin (covers S. pneumoniae including resistant strains)
- Gram stain guides empiric antibiotic selection before culture results (24-48 hours)
Example 3: Endotoxin and Septic Shock β οΈ
Clinical Scenario: A patient with a urinary tract infection develops fever, hypotension, and altered mental status. Blood cultures grow E. coli.
Pathophysiology of Endotoxic Shock:
ENDOTOXIN CASCADE
Gram-negative bacteremia
β
LPS (endotoxin) released
β
Binds to LPS-binding protein (LBP)
β
Complex binds to CD14 on macrophages
β
TLR4 (Toll-like receptor 4) activated
β
NF-ΞΊB pathway activated
β
βββββββ΄ββββββ¬ββββββββββ
β β β
IL-1, IL-6 TNF-Ξ± IL-12
β β β
FEVER HYPOTENSION INFLAMMATION
β β β
ββββββββ¬βββββ΄βββββ¬βββββ
β β
SEPTIC SHOCK DIC
Clinical manifestations:
- Fever: IL-1 and IL-6 β prostaglandin Eβ in hypothalamus
- Hypotension: TNF-Ξ± β vasodilation, increased vascular permeability
- DIC: Widespread activation of coagulation cascade
- Multi-organ failure: Hypoperfusion and inflammatory damage
Key distinctions:
- Endotoxin (Gram-negative): Part of bacterial structure (LPS), heat-stable, weakly immunogenic
- Exotoxin (Gram-positive or Gram-negative): Secreted proteins, heat-labile (usually), strongly immunogenic, can be toxoided
Treatment approach:
- Aggressive fluid resuscitation
- Broad-spectrum antibiotics (early administration critical)
- Vasopressors if needed (norepinephrine first-line)
- Source control (remove infected catheter, drain abscess, etc.)
π‘ USMLE High-Yield: LPS/endotoxin is detected by TLR4, activates NF-ΞΊB, causes release of TNF-Ξ± and IL-1, leading to fever and shock.
Example 4: Bacterial Spore Formation and Clinical Implications π‘οΈ
Clinical Scenario: A patient who recently completed antibiotic therapy develops watery diarrhea. Clostridium difficile is suspected.
Spore formation cycle:
CLOSTRIDIUM LIFE CYCLE
Vegetative cell (growing)
β
Stress (antibiotics, lack of nutrients)
β
Sporulation (6-8 hours)
β
Endospore (dormant, resistant)
β
β Can survive:
β β’ Antibiotics
β β’ Alcohol-based sanitizers
β β’ Desiccation
β β’ Years in environment
β
Favorable conditions
(e.g., antibiotic-altered gut)
β
Germination
β
Vegetative cell (pathogenic)
β
Toxin production (TcdA, TcdB)
β
Pseudomembranous colitis
Why C. difficile infection follows antibiotics:
- Normal flora disrupted: Antibiotics kill competing bacteria
- Spores germinate: C. diff spores survive antibiotic treatment
- Vegetative cells proliferate: Overgrow in altered gut environment
- Toxin production: TcdA (enterotoxin) and TcdB (cytotoxin) damage colonic epithelium
Clinical implications:
- Alcohol sanitizers ineffective: Spores resistant; need soap and water or bleach
- Environmental contamination: Spores persist on surfaces
- Recurrence common: ~20-30% after first episode (spores remain)
- Treatment: Oral vancomycin or fidaxomicin (not IV vancomycinβdoesn't reach colon)
- Prevention: Contact precautions, environmental cleaning with bleach
π¬ Lab diagnosis:
- Stool test for C. difficile toxins (TcdA/TcdB) or toxin genes (NAAT)
- Colonoscopy: Pseudomembranes (yellowish plaques on colonic mucosa)
Common Mistakes to Avoid β οΈ
Mistake 1: Confusing Gram Stain Results with Acid-Fast Staining
β Wrong: "Mycobacterium tuberculosis is Gram-positive because it has a thick cell wall."
β Right: M. tuberculosis does NOT Gram stain well due to high mycolic acid content in its cell wall. It requires acid-fast staining (Ziehl-Neelsen or Kinyoun stain). Acid-fast bacteria appear red/pink, while non-acid-fast bacteria appear blue.
Why this matters: Requesting a Gram stain for suspected TB will yield poor results. Always order acid-fast bacilli (AFB) staining for mycobacteria.
Mistake 2: Assuming All Antibiotics Work on All Bacteria
β Wrong: "Vancomycin is a strong antibiotic, so it should work against Pseudomonas aeruginosa."
β Right: Vancomycin only works against Gram-positive bacteria (targets D-Ala-D-Ala in peptidoglycan synthesis). It CANNOT penetrate the outer membrane of Gram-negative bacteria. For P. aeruginosa, use antipseudomonal Ξ²-lactams (piperacillin-tazobactam, cefepime, carbapenems, ceftazidime) or fluoroquinolones.
Why this matters: Using the wrong antibiotic class leads to treatment failure and potential patient harm.
Mistake 3: Thinking Endotoxin = Exotoxin
β Wrong: "All bacterial toxins are proteins that can be neutralized by antibodies."
β Right:
- Endotoxin (LPS): Lipopolysaccharide component of Gram-negative outer membrane, heat-stable, weakly immunogenic, cannot be toxoided
- Exotoxin: Secreted protein toxins (can be from Gram-positive or Gram-negative bacteria), heat-labile, strongly immunogenic, can be converted to toxoids for vaccines
Why this matters: Understanding toxin types explains vaccine strategies (e.g., diphtheria and tetanus toxoid vaccines work because exotoxins can be inactivated while maintaining immunogenicity).
Mistake 4: Forgetting That Bactericidal Antibiotics Only Work on Growing Cells
β Wrong: "Ξ²-lactam antibiotics should kill all bacteria including dormant spores."
β Right: Ξ²-lactams (and most bactericidal antibiotics) only work on actively dividing bacteria that are synthesizing cell walls. Spores, persister cells, and bacteria in stationary phase are not killed.
Why this matters: This explains:
- Why C. difficile spores survive antibiotic treatment
- Why biofilm infections are difficult to eradicate
- Why prolonged antibiotic courses are needed for certain infections (to catch bacteria as they emerge from dormancy)
Mistake 5: Confusing Capsule with Cell Wall
β Wrong: "The capsule is what makes bacteria Gram-positive or Gram-negative."
β Right: The cell wall (specifically peptidoglycan thickness and presence/absence of outer membrane) determines Gram stain result. The capsule is an additional outer layer (when present) that serves mainly as an antiphagocytic virulence factor.
Why this matters: Some Gram-negative bacteria have capsules (E. coli K1), and some Gram-positive bacteria lack capsules. The two structures serve different functions.
Key Takeaways π―
Prokaryotic cells lack membrane-bound organelles and have 70S ribosomes (target for many antibiotics) vs. 80S in eukaryotes
Peptidoglycan (unique to bacteria) consists of NAG-NAM glycan chains cross-linked by peptide bridgesβthe target of Ξ²-lactam antibiotics
Gram-positive bacteria have thick peptidoglycan and retain crystal violet (purple), while Gram-negative bacteria have thin peptidoglycan, outer membrane with LPS, and stain pink
LPS (endotoxin) in Gram-negative bacteria contains Lipid A (toxic component), triggers TLR4, causes cytokine release (TNF-Ξ±, IL-1, IL-6), and can lead to septic shock
Capsules are antiphagocytic virulence factors; encapsulated bacteria cause severe infections in asplenic patients and are vaccine targets
Endospores (formed by Bacillus and Clostridium) are extremely resistant structures requiring sterilization (autoclaving) for elimination
Obligate aerobes require oxygen and have catalase/SOD; obligate anaerobes are killed by oxygen due to lack of protective enzymes
Bacterial chromosome is circular, haploid, and located in nucleoid; plasmids carry antibiotic resistance and virulence genes and can be transferred between bacteria
Ξ²-lactam antibiotics inhibit transpeptidases (PBPs), preventing peptidoglycan cross-linking, leading to cell lysis in growing bacteria
Understanding bacterial structure is essential for rational antibiotic selection, laboratory identification, and vaccine development
π Quick Reference Card: Bacterial Structure Essentials
| Structure | Function | Clinical Significance |
|---|---|---|
| Peptidoglycan | Rigid cell wall support | Target of Ξ²-lactams, lysozyme; basis for Gram stain |
| LPS (Gram-neg) | Outer membrane component | Endotoxin; causes septic shock via TLR4 |
| Capsule | Antiphagocytic protection | Major virulence factor; vaccine target |
| Flagella | Motility | H antigen for serotyping |
| Pili | Attachment, conjugation | Virulence (adhesion); gene transfer |
| Endospore | Survival in harsh conditions | Requires sterilization; survives antibiotics |
| 70S Ribosome | Protein synthesis | Target of aminoglycosides, tetracyclines, macrolides |
| Plasmid | Extrachromosomal DNA | Antibiotic resistance; horizontal gene transfer |
π§ Quick Mnemonics:
- Gram-negative outer membrane: "POLLEN" (Periplasm, Outer membrane, LPS, Less peptidoglycan, Endotoxin, Negative stain)
- Encapsulated organisms: "Please SHINES my SKiS"
- Obligate anaerobes: "Anaerobes Can't Breathe Air" (Actinomyces, Clostridium, Bacteroides)
- Spore-formers: "Bacillus and Clostridium make Spores"
Further Study π
For deeper understanding of bacterial cell structure and clinical applications:
CDC - Antibiotic Resistance & Patient Safety Portal: https://www.cdc.gov/drugresistance/index.html - Comprehensive information on how bacterial structures contribute to antibiotic resistance
NCBI Bookshelf - Medical Microbiology (Baron): https://www.ncbi.nlm.nih.gov/books/NBK7627/ - Free, detailed textbook chapters on bacterial structure and physiology
UpToDate - Gram Stain and Bacterial Identification: https://www.uptodate.com - Subscription resource with clinical pearls on using bacterial structural features for diagnosis (available through most medical institutions)